ATCC®
No. |
Source
Cell Line
|
Description
|
|
|
Human
|
|
|
CRL-2098D
|
SJSA-1
|
bone, osteosarcoma; multipotential
|
|
|
HTB-38D
|
HT-29
|
colon; colorectal adenocarcinoma
|
|
|
CRL-1573D
|
293
|
embryonal kidney
|
|
|
CCL-243D
|
K-562
|
bone marrow, granulocyte; chronic myelogenous leukemia
|
|
|
45507
|
|
same as above except available in 100 µg
|
|
|
CRL-11731D
|
TOV-112D
|
ovary; primary malignant adenocarcinoma
|
|
|
CCL-155D
|
RPMI 8226
|
plasmacytoma; myeloma
|
|
|
CCL-240D
|
HL-60
|
peripheral blood; promyeloblast; acute promyelocytic leukemia
|
|
|
CCL-123D
|
C 211
|
skin fibroblast; Cri du Chat syndrome
|
|
|
CCL-90D
|
Cri du Chat
|
skin fibroblast; Cri du Chat syndrome
|
|
|
CCL-66D
|
Detroit 529
|
skin fibroblast; Down syndrome
|
|
|
CCL-54D
|
Detroit 532
|
skin fibroblast; Down syndrome
|
|
|
CRL-2704D
|
C13589
|
fraglie X syndrome; EBV-transformed B lymphoblast
|
|
|
CCL-28D
|
Dempsey
|
skin fibroblast; Klinefelter syndrome
|
|
|
CCL-65D
|
Detroit 525
|
skin fibroblast; Turner syndrome
|
|
|
|
|
|
Human breast cancer cell DNA
|
|
|
HTB-20D
|
BT-474
|
mammary gland ductal carcinoma
|
|
|
HTB-121D
|
BT-483
|
mammary gland ductal carcinoma
|
|
|
HTB-126D
|
Hs 578T
|
mammary gland carcinoma
|
|
|
HTB-22D
|
MCF7
|
mammary gland ductal carcinoma; pleural effusion
|
|
|
HTB-25D
|
MDA-MB-175-VII
|
mammary gland ductal carcinoma; pleural effusion
|
|
|
HTB-26D
|
MDA-MB-231
|
mammary gland ductal carcinoma; pleural effusion
|
|
|
HTB-128D
|
MDA-MB-415
|
mammary gland; adenocarcinoma
|
|
|
HTB-129D
|
MDA-MB-435S
|
mammary gland ductal carcinoma; pleural effusion
|
|
|
HTB-30D
|
SK-BR-3
|
mammary gland ductal adenocarinoma; pleural effusion, malignant
|
|
|
HTB-133D
|
T-47D
|
mammary gland ductal carcinoma; pleural effusion
|
|
|
CRL-1897D
|
UACC-812
|
mammary gland ductal carcinoma
|
|
|
CRL-1902D
|
UACC-893
|
mammary gland ductal carcinoma; primary
|
|
|
CRL-1500D
|
ZR-75-1
|
mammary gland ductal carcinoma
|
|
|
CRL-1504D
|
ZR-75-30
|
mammary gland ductal carcinoma
|
|
|
|
|
|
Human breast: Normal and cancer cell DNA from the same individual
|
|
|
CRL-2319D
|
HCC1007 BL
|
B lymphoblast; peripheral blood; EBV transformed
|
|
|
CRL-2320D
|
HCC1008
|
metastatic lymph node from ductal carcinoma TNM stage IIA; grade 3
|
|
|
|
|
|
CRL-2362D
|
HCC1143 BL
|
B lymphoblast; peripheral blood; EBV transformed
|
|
|
CRL-2321D
|
HCC1143
|
primary ductal carcinoma; no lymph node metastases
|
|
|
|
|
|
CRL-2323D
|
HCC1187 BL
|
B lymphoblast; peripheral blood; EBV transformed
|
|
|
CRL-2322D
|
HCC1187
|
primary ductal carcinoma TNM stage IIA; grade 3
|
|
|
|
|
|
CRL-2325D
|
HCC1395 BL
|
B lymphoblast; peripheral blood; EBV transformed
|
|
|
CRL-2324D
|
HCC1395
|
primary ductal carcinoma TNM stage I; grade 3
|
|
|
|
|
|
CRL-2332D
|
HCC1599 BL
|
B lymphoblast; peripheral blood; EBV transformed
|
|
|
CRL-2331D
|
HCC1599
|
primary ductal carcinoma TNM stage IIIA; grade 3
|
|
|
|
|
|
CRL-2337D
|
HCC1937 BL
|
B lymphoblast; peripheral blood; EBV transformed
|
|
|
CRL-2336D
|
HCC1937
|
primary ductal carcinoma TNM stage IIB; grade 3
|
|
|
|
|
|
CRL-2339D
|
HCC1954 BL
|
B lymphoblast; peripheral blood; EBV transformed
|
|
|
CRL-2338D
|
HCC1954
|
primary ductal carcinoma TNM stage IIA; grade 3
|
|
|
|
|
|
CRL-2341D
|
HCC2157 BL
|
B lymphoblast; peripheral blood; EBV transformed
|
|
|
CRL-2340D
|
HCC2157
|
primary ductal carcinoma TNM stage IIIA; grade 2
|
|
|
|
|
|
CRL-2363D
|
HCC2218 BL
|
B lymphoblast; peripheral blood; EBV transformed
|
|
|
CRL-2343D
|
HCC2218
|
primary ductal carcinoma; metastatic
|
|
|
|
|
|
CRL-2346D
|
HCC38 BL
|
B lymphoblast; peripheral blood; EBV transformed
|
|
|
CRL-2314D
|
HCC38
|
primary ductal carcinoma TNM stage IIB; grade 3
|
|
|
|
|
|
Human liver
|
|
|
HB-8064D
|
Hep 382.1-7
|
hepatocellular carcinoma
|
|
|
HB-8065D
|
Hep G2
|
hepatocellular carcinoma
|
|
|
CRL-2235D
|
SNU-182
|
hepatocellular carcinoma
|
|
|
|
|
|
Human lung
|
|
|
HTB-119D
|
NCI-H69
|
small cell lung carcinoma
|
|
|
CRL-5807D
|
NCI-H358
|
non-small cell lung carcinoma; bronchioalveolar
|
|
|
CRL-5811D
|
NCI-H526
|
small cell lung carcinoma, variant from bone marrow metastasis
|
|
|
CRL-5803D
|
NCI-H1299
|
non-small cell carcinoma; from lymph node metastasis
|
|
|
|
|
|
Human lung: Normal and cancer cell DNA from the same individual
|
|
|
CRL-5957D
|
NCI-BL1395
|
B lymphoblast; peripheral blood; EBV transformed
|
|
|
CRL-5868D
|
NCI-H1395
|
adenocarcinoma; stage 2
|
|
|
|
|
|
CCL-256.1D
|
NCI-BL2126
|
B lymphoblast; peripheral blood; EBV transformed
|
|
|
CCL-256D
|
NCI-H2126
|
non-small cell lung carcinoma
|
|
|
|
|
|
Human melanoma
|
|
|
CRL-11147D
|
A2058
|
melanoma, from lynph node metastasis
|
|
|
CRL-1424D
|
G-361
|
malignant melonoma
|
|
|
HTB-72D
|
SK-MEL-28
|
skin; malignant melonoma
|
|
|
CRL-1675D
|
WM-115
|
melonoma
|
|
|
|
|
|
Human prostate
|
|
|
CRL-2505D
|
22Rv1
|
prostate; carcinoma
|
|
|
HTB-81D
|
DU 145
|
prostate; carcinoma, from brain metastasis
|
|
|
CRL-1740D
|
LNCaP clone FGC
|
prostate; carcinoma, from lymph node metastasis
|
|
|
CRL-2422D
|
MDA PCa 2b
|
prostate; adenocarcinoma, from bone metastasis
|
|
|
CRL-1435D
|
PC-3
|
prostate; adenocarcinoma, from bone metastasis
|
|
|
CRL-2221D
|
PZ-HPV-7
|
prostate; transformed by HPV-18
|
|
|
CRL-11609D
|
RWPE-1
|
prostate; transformed by HPV-18
|
|
|
CRL-11610D
|
RWPE-2
|
prostate; transformed by HPV-18 and transformed by Ki-MSV
|
|
|
|
|
|
Mink
|
|
|
CCL-64D
|
Mv 1 Lu (NBL-7)
|
mink lung
|
|
|
|
|
|
Monkey, African Green
|
|
|
CRL-1587D
|
VERO 76
|
kidney
|
|